Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Statistics

Total Valuation

AVXL has a market cap or net worth of $937.38 million. The enterprise value is $821.61 million.

Market Cap	937.38M
Enterprise Value	821.61M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

AVXL has 85.37 million shares outstanding. The number of shares has increased by 3.60% in one year.

Current Share Class	85.37M
Shares Outstanding	85.37M
Shares Change (YoY)	+3.60%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	3.33%
Owned by Institutions (%)	37.08%
Float	82.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	11.56
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.39
P/TBV Ratio	9.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.74

Current Ratio	6.74
Quick Ratio	6.70
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -40.17% and return on invested capital (ROIC) is -28.36%.

Return on Equity (ROE)	-40.17%
Return on Assets (ROA)	-25.44%
Return on Invested Capital (ROIC)	-28.36%
Return on Capital Employed (ROCE)	-53.37%
Revenue Per Employee	n/a
Profits Per Employee	-$1.12M
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +85.47% in the last 52 weeks. The beta is 0.72, so AVXL's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+85.47%
50-Day Moving Average	8.95
200-Day Moving Average	8.67
Relative Strength Index (RSI)	61.87
Average Volume (20 Days)	1,076,554

Short Selling Information

The latest short interest is 25.12 million, so 29.43% of the outstanding shares have been sold short.

Short Interest	25.12M
Short Previous Month	25.21M
Short % of Shares Out	29.43%
Short % of Float	30.44%
Short Ratio (days to cover)	28.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-53.24M
Pretax Income	-41.47M
Net Income	-47.14M
EBITDA	n/a
EBIT	-53.24M
Earnings Per Share (EPS)	-$0.56

Balance Sheet

The company has $115.77 million in cash and n/a in debt, giving a net cash position of $115.77 million or $1.36 per share.

Cash & Cash Equivalents	115.77M
Total Debt	n/a
Net Cash	115.77M
Net Cash Per Share	$1.36
Equity (Book Value)	99.76M
Book Value Per Share	1.17
Working Capital	99.76M

Cash Flow

Operating Cash Flow	-29.81M
Capital Expenditures	n/a
Free Cash Flow	-29.81M
FCF Per Share	-$0.35

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVXL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.60%
Shareholder Yield	-3.60%
Earnings Yield	-5.03%
FCF Yield	-3.18%

Analyst Forecast

The average price target for AVXL is $44.00, which is 300.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$44.00
Price Target Difference	300.73%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 7, 2015. It was a reverse split with a ratio of 0.25:1.

Last Split Date	Oct 7, 2015
Split Type	Reverse
Split Ratio	0.25:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1